Compound 892
Identifiers
- Canonical SMILES:
Fc1ccc(cc1Cl)-c1c(nc(-c2ccc3sccc3c2)n1-c1cccc(Cl)c1F)-c1nn[nH]n1
- InChi:
InChI=1S/C24H12Cl2F2N6S/c25-15-2-1-3-18(20(15)28)34-22(13-4-6-17(27)16(26)11-13)21(23-30-32-33-31-23)29-24(34)14-5-7-19-12(10-14)8-9-35-19/h1-11H,(H,30,31,32,33)
- InChiKey:
BEZWXBGMLGMHSE-UHFFFAOYSA-N
External links
67032583 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.59 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 524.02 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 7.71 | |||
TPSA | 72.28 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 19 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.59 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4372 | Cimicoxib | DB05095 | |
0.4357 | Ralimetinib | DB11787 | |
0.4340 | Azeliragon | DB12689 | |
0.4068 | Losartan | DB00678 | |
0.4023 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.3992 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.3902 | Miransertib | DB14982 | |
0.3896 | 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine | DB08076 | |
0.3886 | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE | DB08522 | |
0.3843 | 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole | DB03980 | |
0.3837 | TAS-117 | DB15054 | |
0.3832 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | DB08521 | |
0.3821 | Olmesartan | DB00275 | |
0.3789 | Otenabant | DB11745 | |
0.3787 | N-6022 | DB12206 |